Angiotensin-converting enzyme gene polymorphisms and the risk of psoriasis: A meta-analysis

Clinical and Experimental Dermatology

Volumn 38, Issue 4, 2013, Pages 352-359

  Liu, T ^a   Han, Y ^a   Lu, L ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PSORIASIS;

EID: 84876736430     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12106     Document Type: Article

References (25)

1. Gniadecki R, Zachariae C, Calverley M,. Trends and developments in the pharmacological treatment of psoriasis. Acta Derm Venereol 2002; 82: 401-10.
2. Brazzelli V, Carugno A, Alborghetti A, et al,. Hepatitis C infection in Italian psoriatic patients. prevalence and correlation with patient age and psoriasis severity. J Eur Acad Dermatol Venereol 2012; 26: 1581-2.
3. Rongioletti F, Fiorucci C, Parodi A,. Psoriasis induced or aggravated by drugs. J Rheumatol Suppl 2009; 83: 59-61.
4. Naldi L, Parazzini F, Brevi A, et al,. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 1992; 127: 212-17.
5. Liu Y, Krueger JG, Bowcock AM,. Psoriasis. genetic associations and immune system changes. Genes Immun 2007; 8: 1-12.
6. Grjibovski AM, Olsen AO, Magnus P, Harris JR,. Psoriasis in Norwegian twins: contribution of genetic and environmental effects. J Eur Acad Dermatol Venereol 2007; 21: 1337-43.
7. Giardina E, Sinibaldi C, Novelli G,. Mapping the future of common diseases: lessons from psoriasis. Front Biosci 2007; 12: 1563-73.
8. Capon F, Burden AD, Trembath RC, Barker JN,. Psoriasis and other complex trait dermatoses: from loci to functional pathways. J Invest Dermatol 2012; 132: 915-22.
9. Ozkur M, Erbagci Z, Nacak M, et al,. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with psoriasis. Br J Dermatol 2004; 151: 792-5.
10. Lembeck F, Griesbacher T, Eckhardt M,. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations. Br J Pharmacol 1990; 100: 49-54.
11. Crisan D, Carr J,. Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn 2000; 2: 105-15.
12. Chang YC, Wu WM, Chen CH, et al,. Association between the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and risk for psoriasis in a Chinese population in Taiwan. Br J Dermatol 2007; 156: 642-5.
13. Weger W, Hofer A, Wolf P, et al,. The angiotensin-converting enzyme insertion/deletion and the endothelin-134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis. Exp Dermatol 2007; 16: 993-8.
14. Liu XH, Zhao SP, Zhao ZQ, et al,. Study on the relationship between insertion/deletion polymorphism of angiotensin-converting enzyme gene with psoriasis. Chin J Derm Venere 2007; 21: 199-200.
15. Veletza S, Karpouzis A, Giassakis G, et al,. Assessment of insertion/deletion polymorphism of the angiotensin converting enzyme gene in psoriasis. J Dermatol Sci 2008; 49: 85-7.
16. Coto-Segura P, Alvarez V, Soto-Sanchez J, et al,. Lack of association between angiotensin I-converting enzyme insertion/deletion polymorphism and psoriasis or psoriatic arthritis in Spain. Int J Dermatol 2009; 48: 1320-3.
17. Vašků V, Vašků A, Hollá LL, et al,. Interaction of five gene polymorphisms at psoriasis. J Invest Dermatol 1999; 113: 494. (abstract 380).
18. Nagui NA, Abdel Hay RM, Rashed L,. Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and the risk for psoriasis. J Egypt Women Dermatol Soc 2012; 9: 14-17.
19. Al-Awadhi AM, Hasan EA, Sharma PN, et al,. Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis. Rheumatol Int 2007; 27: 1119-23.
20. Steckelings UM, Wollschlager T, Peters J, et al,. Human skin: source of and target organ for angiotensin II. Exp Dermatol 2004; 13: 148-54.
21. Morihara K, Takai S, Takenaka H, et al,. Cutaneous tissue angiotensin-converting enzyme may participate in pathologic scar formation in human skin. J Am Acad Dermatol 2006; 54: 251-7.
22. Scholzen TE, Stander S, Riemann H, et al,. Modulation of cutaneous inflammation by angiotensin-converting enzyme. J Immunol 2003; 170: 3866-73.
23. Mizuiri S, Hemmi H, Kumanomidou H, et al,. Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int 2001; 60: 1124-30.
24. Henseler T,. The genetics of psoriasis. J Am Acad Dermatol 1997; 37: S1-11.
25. Lau J, Ioannidis JP, Terrin N, et al,. The case of the misleading funnel plot. BMJ 2006; 333: 597-600.